Cite

    Faehling, M. et al. (2021). Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option. European journal of cancer. pp. 175-186. [Online].